New Treatment
-
{
- All
- News
- Videos
- Web Stories
-
A Simple Blood Test May Detect Hidden Heart Failure In Diabetes Patients Early
A new trial shows a simple blood test can detect undiagnosed heart failure in people with diabetes. Early screening could improve diagnosis, enable timely treatment, and reduce hospitalisation and death risks significantly.
-
New Study Explains Why Ozempic Doesn't Work For Everyone
A new study published in Genome Medicine details that Ozempic doesn't work for everyone in the same manner. Here is what you need to know about its mechanisms and why making science-based medical decisions is important.
-
Testicular Cancer In Young Men: 7 Signs You Might Be Missing That Can Help In Early Detection
Testicular cancer is one of the most treatable cancers when detected early. Knowing the early signs can help you in early detection and better treatment results.
-
Struggling To Lose Weight On Ozempic, Mounjaro? Study Says Your Genes Might Be the Hurdle
A new study reveals that your genes could be the hidden hurdle, explaining the differences in how bodies respond to weight loss drugs.
-
Is Your Morning Back Pain More Than Just 'Stiffness'? New Cryotherapy Could Be The Answer
Morning back pain can signal more than just back muscle stiffness. A new review suggests that whole body cryotherapy could be the answer to address ankylosing spondylitis.
-
Can Low Birthweight Predict Stroke Risk? Doctor Breaks Down New Swedish Study
Low birth weight is linked to a higher risk of stroke in early adulthood, affecting both ischemic and hemorrhagic stroke types.
-
Centre Revises Coronary Stent Prices From April 2026: Here's How Much It Should Cost You Now
National Pharmaceutical Pricing Authority revises stent prices, DES capped at Rs 39,186, BMS at Rs 10,762, effective April 2026.
-
Asthma Treatment Breakthrough: Could This Single Drug End Inhaler Dependency For Millions?
A new asthma drug named Lunsekimig could be the answer for millions who remain dependent on inhalers. Here is what the phase 2 trials of the drug signal, and why it shows promise for better asthma management.
-
New Diabetes Generic Drug Gets Approval In US Market: All About Dapagliflozin
Zydus Lifesciences has received USFDA approval for generic dapagliflozin tablets used to treat type 2 diabetes. Here's how the drug works, its benefits, and why it is important for blood sugar control and heart health.
-
Liver Disease Identified As the 'Fourth Major Complication' Of Diabetes, Says Lancet Study
Researchers analysed over 9,000 patients using a tool called FibroScan, which measures liver stiffness without needles or surgery.
-
A Simple Blood Test May Detect Hidden Heart Failure In Diabetes Patients Early
A new trial shows a simple blood test can detect undiagnosed heart failure in people with diabetes. Early screening could improve diagnosis, enable timely treatment, and reduce hospitalisation and death risks significantly.
-
New Study Explains Why Ozempic Doesn't Work For Everyone
A new study published in Genome Medicine details that Ozempic doesn't work for everyone in the same manner. Here is what you need to know about its mechanisms and why making science-based medical decisions is important.
-
Testicular Cancer In Young Men: 7 Signs You Might Be Missing That Can Help In Early Detection
Testicular cancer is one of the most treatable cancers when detected early. Knowing the early signs can help you in early detection and better treatment results.
-
Struggling To Lose Weight On Ozempic, Mounjaro? Study Says Your Genes Might Be the Hurdle
A new study reveals that your genes could be the hidden hurdle, explaining the differences in how bodies respond to weight loss drugs.
-
Is Your Morning Back Pain More Than Just 'Stiffness'? New Cryotherapy Could Be The Answer
Morning back pain can signal more than just back muscle stiffness. A new review suggests that whole body cryotherapy could be the answer to address ankylosing spondylitis.
-
Can Low Birthweight Predict Stroke Risk? Doctor Breaks Down New Swedish Study
Low birth weight is linked to a higher risk of stroke in early adulthood, affecting both ischemic and hemorrhagic stroke types.
-
Centre Revises Coronary Stent Prices From April 2026: Here's How Much It Should Cost You Now
National Pharmaceutical Pricing Authority revises stent prices, DES capped at Rs 39,186, BMS at Rs 10,762, effective April 2026.
-
Asthma Treatment Breakthrough: Could This Single Drug End Inhaler Dependency For Millions?
A new asthma drug named Lunsekimig could be the answer for millions who remain dependent on inhalers. Here is what the phase 2 trials of the drug signal, and why it shows promise for better asthma management.
-
New Diabetes Generic Drug Gets Approval In US Market: All About Dapagliflozin
Zydus Lifesciences has received USFDA approval for generic dapagliflozin tablets used to treat type 2 diabetes. Here's how the drug works, its benefits, and why it is important for blood sugar control and heart health.
-
Liver Disease Identified As the 'Fourth Major Complication' Of Diabetes, Says Lancet Study
Researchers analysed over 9,000 patients using a tool called FibroScan, which measures liver stiffness without needles or surgery.
